methoxsalen has been researched along with Erythema in 69 studies
Methoxsalen: A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation.
methoxsalen : A member of the class of psoralens that is 7H-furo[3,2-g]chromen-7-one in which the 9 position is substituted by a methoxy group. It is a constituent of the fruits of Ammi majus. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered topically or orally in conjunction with UV-A for phototherapy treatment of vitiligo and severe psoriasis.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Limited data exist in the literature concerning the characteristics of erythema following psoralen UV-A (PUVA) treatment using topical methoxsalen." | 7.72 | The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion. ( Dawe, RS; Ferguson, J; Ibbotson, SH; Kwok, YK; Man, I, 2003) |
| "We compared the characteristics of psoralen and ultraviolet A (PUVA) erythema in skin photosensitized by bath or oral methoxsalen in 20 subjects." | 7.72 | An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B. ( Dawe, RS; Ferguson, J; Ibbotson, SH; Man, I, 2003) |
| "There is considerable interindividual variation in bioavailability of Methoxsalen (8-methoxypsoralen) after ingestion of the standard dose used in photochemotherapy (psoralen plus ultraviolet A)." | 5.31 | The effect of methoxsalen dose on ultraviolet-A-induced erythema. ( Dawe, RS; Farr, PM; Ibbotson, SH, 2001) |
| "Successful results have been reported for bath-psoralens plus ultraviolet A (PUVA) treatment of psoriasis with the use of either a low-sensitizing psoralen (methoxsalen) or a high-sensitizing psoralen (trioxsalen), but no evidence has been presented that phototoxicity would be a prerequisite for antipsoriatic activity of these treatments." | 5.06 | Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization. ( Jansén, CT; Koulu, LM, 1988) |
| "Because heat has been reported to influence adversely short- and long-term ultraviolet (UV)-radiation-induced skin damage in animals, we investigated the short-term effects of infrared radiation on sunburn and on phototoxic reactions to topical methoxsalen and anthracene in human volunteers." | 5.05 | The influence of infrared radiation on short-term ultraviolet-radiation-induced injuries. ( Kaidbey, KH; Kligman, AM; Witkowski, TA, 1982) |
| "5-Methoxypsoralen (5-MOP) (Psoraderm 5) tablets obtained from France and 5-MOP micronized in capsules (manufactured in our pharmacy department) were administered to seven psoriasis patients in a 1." | 3.67 | Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen. ( Cormane, RH; Siddiqui, AH; Stolk, LM; Westerhof, W, 1985) |
| "Threshold erythema was unaffected by ingestion of a 200-g portion of parsnip." | 1.34 | Can dietary furanocoumarin ingestion enhance the erythemal response during high-dose UVA1 therapy? ( Beattie, PE; Ferguson, J; Ibbotson, SH; Smith, G; Wilkie, MJ, 2007) |
| "We sought to determine the time-course and dose-response characteristics of erythema induced by topical TMP, and to compare these parameters with those for topical 8-methoxypsoralen (MOP) within patients." | 1.32 | An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen. ( Dawe, RS; Ferguson, J; Ibbotson, SH; Man, I; McKinlay, J, 2003) |
| " However, the mean slope of erythema dose-response on the 15-min treated side was significantly steeper than on the 5-min treated side, 0." | 1.31 | Reduction in 8-methoxypsoralen immersion time alters the erythemal response to bath PUVA. ( Azurdia, RM; Dean, MP; Rhodes, LE, 2000) |
| "Histopathology revealed skin phototoxicity of compounds which lacked erythemogenic activity by visual scoring." | 1.30 | Antiproliferative activity and phototoxicity of some methyl derivatives of 5-methoxypsoralen and 5-methoxyangelicin. ( Conconi, MT; Montesi, F; Parnigotto, PP, 1998) |
| " Observations on the time-course and dose-response characteristics of PUVA erythema suggest that larger doses of UVA could be used safely, provided that the frequency of PUVA treatment is reduced." | 1.29 | Response of psoriasis to twice weekly PUVA. ( Farr, PM; Sakuntabhai, A; Sharpe, GR, 1993) |
| " The erythema responses were judged visually, and also measured using a reflectance instrument in order to construct dose-response curves." | 1.29 | PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity. ( Diffey, BL; Farr, PM; Sakuntabhai, A, 1993) |
| "Erythema was graded visually." | 1.28 | Photoinduced cutaneous inflammatory response by psoralens. ( Haberman, HF; Kumar, JR; Menon, IA; Ranadive, NS, 1992) |
| " The resulting erythema was measured objectively 72 h after irradiation and dose-response curves for psoralen-UVA erythema were constructed." | 1.28 | The relationship between plasma psoralen concentration and psoralen-UVA erythema. ( Cox, NH; Diffey, BL; Farr, PM; Fisher, C; Mclelland, J, 1991) |
| " The dose-response curve is steeper, with blistering reactions occurring in some subjects after as little as three to four times the minimum phototoxic dose of UV radiation at 320-400 nm (UVA)." | 1.27 | Cutaneous phototoxicity due to psoralens. ( Gange, RW; Parrish, JA, 1984) |
| "Erythema was evaluated 3 and 5 d later, and an action spectrum for prolonged sensitization was determined." | 1.27 | An action spectrum for photoinduction of prolonged cutaneous photosensitivity by topical 8-MOP. ( Anderson, RR; Gange, RW; Gold, RL; Natoli, VD, 1988) |
| "The results of the first six months of treatment of psoriasis with photochemotherapy in the Skin and Cancer Foundation's clinic resulted in 30 out of 53 patients being completely clear of psoriasis lesions, 14 showing progressive improvement (and subsequently clearing), four failures, and five withdrawals." | 1.26 | Photochemotherapy in psoriasis: the first six months in Australia. ( King, R; O'Brien, H; Paver, K; Poyzer, K, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (56.52) | 18.7374 |
| 1990's | 15 (21.74) | 18.2507 |
| 2000's | 11 (15.94) | 29.6817 |
| 2010's | 4 (5.80) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wainwright, LK | 1 |
| Parisi, AV | 1 |
| Downs, NJ | 1 |
| Al-Ismail, D | 1 |
| Edwards, C | 1 |
| Anstey, AV | 1 |
| Berroeta, L | 1 |
| Attili, S | 1 |
| Wong, A | 1 |
| Man, I | 4 |
| Dawe, RS | 6 |
| Ferguson, J | 6 |
| Ibbotson, SH | 7 |
| Dinkova-Kostova, AT | 1 |
| Weidlich, S | 1 |
| Farr, PM | 5 |
| Wolf, CR | 1 |
| Smith, G | 2 |
| Leigh, H | 1 |
| Forbes, PD | 2 |
| Lawson, C | 1 |
| Kim, DY | 1 |
| White, D | 1 |
| Brown, LD | 1 |
| Wehmeier, DR | 1 |
| Liu, J | 1 |
| Bouchard, GF | 1 |
| Kwok, YK | 1 |
| McKinlay, J | 1 |
| IMBRIE, JD | 2 |
| DANIELS, F | 1 |
| BERGERON, L | 1 |
| HOPKINS, CE | 1 |
| FITZPATRICK, TB | 4 |
| CAHN, MM | 1 |
| LEVY, EJ | 1 |
| SHAFFER, B | 1 |
| HAKIM, RE | 1 |
| GRIFFIN, AC | 1 |
| KNOX, JM | 1 |
| BERGERON, LL | 1 |
| BUCK, HW | 1 |
| MAGNUS, IA | 1 |
| PORTER, AD | 1 |
| Beattie, PE | 1 |
| Wilkie, MJ | 1 |
| Rodríguez-Granados, MT | 1 |
| Carrascosa, JM | 1 |
| Gárate, T | 1 |
| Gómez-Díez, S | 1 |
| Guimaraens-Juantorena, D | 1 |
| Coupez, L | 1 |
| Agache, PG | 1 |
| Petigny, M | 1 |
| Gange, RW | 4 |
| Parrish, JA | 5 |
| Meffert, H | 1 |
| Andersen, KE | 1 |
| Sönnichsen, N | 1 |
| Abijev, GA | 1 |
| Roshchupkin, DI | 1 |
| Pliquett, F | 2 |
| Ermolayev, AV | 1 |
| Sarycheva, IK | 1 |
| Evstigneeva, RP | 1 |
| Morison, WL | 1 |
| Bloch, KJ | 1 |
| Krugler, JI | 1 |
| Kaidbey, KH | 3 |
| Witkowski, TA | 1 |
| Kligman, AM | 3 |
| Potapenko, AIa | 1 |
| Abiev, GA | 1 |
| Zagotto, G | 1 |
| Gia, O | 2 |
| Baccichetti, F | 1 |
| Uriarte, E | 1 |
| Palumbo, M | 2 |
| Bech-Thomsen, N | 1 |
| Wulf, HC | 1 |
| Sakuntabhai, A | 2 |
| Sharpe, GR | 1 |
| Diffey, BL | 2 |
| González, S | 1 |
| Pathak, MA | 1 |
| Kumar, JR | 3 |
| Haberman, HF | 3 |
| Ranadive, NS | 3 |
| Schempp, CM | 1 |
| Schöpf, E | 1 |
| Simon, JC | 1 |
| Conconi, MT | 1 |
| Montesi, F | 1 |
| Parnigotto, PP | 1 |
| Calzavara-Pinton, P | 1 |
| Yeo, UC | 1 |
| Shin, JH | 1 |
| Yang, JM | 1 |
| Park, KB | 1 |
| Kim, MM | 1 |
| Bok, HS | 1 |
| Lee, ES | 1 |
| Dolezal, E | 1 |
| Seeber, A | 1 |
| Hönigsmann, H | 3 |
| Tanew, A | 1 |
| Azurdia, RM | 1 |
| Dean, MP | 1 |
| Rhodes, LE | 1 |
| Schiener, R | 1 |
| Behrens-Williams, SC | 1 |
| Pillekamp, H | 1 |
| Kaskel, P | 1 |
| Peter, RU | 1 |
| Kerscher, M | 1 |
| Savin, RC | 1 |
| Greaves, MW | 1 |
| Hensby, CN | 1 |
| Black, AK | 1 |
| Plummer, NA | 1 |
| Fincham, N | 1 |
| Warin, AP | 1 |
| Camp, R | 1 |
| Rosten, M | 1 |
| Wolff, K | 1 |
| Gschnait, F | 1 |
| Konrad, K | 1 |
| Eaglstein, WH | 1 |
| Sakai, M | 1 |
| Mizuno, N | 2 |
| Rosario, R | 1 |
| Mark, GJ | 1 |
| Mihm, MC | 1 |
| Plewig, G | 1 |
| Hofmann, C | 1 |
| Braun-Falco, O | 1 |
| Nath, G | 1 |
| Kreitmair, A | 1 |
| King, R | 1 |
| Poyzer, K | 1 |
| Paver, K | 1 |
| O'Brien, H | 1 |
| Melski, JW | 1 |
| Tanenbaum, L | 1 |
| Bleich, HL | 1 |
| Davies, RE | 1 |
| Urbach, F | 1 |
| Schaefer, H | 1 |
| Vivell, K | 1 |
| Kentsch, V | 1 |
| Schalla, W | 1 |
| Jenny, S | 1 |
| Menon, IA | 1 |
| Jeanmougin, M | 1 |
| Manciet, JR | 1 |
| Castelneau, JP | 1 |
| Smadja, J | 1 |
| Dubertret, L | 1 |
| Gasparro, FP | 1 |
| Mclelland, J | 1 |
| Fisher, C | 1 |
| Cox, NH | 1 |
| Ortel, B | 1 |
| Imokawa, G | 1 |
| Tejima, T | 1 |
| Koulu, LM | 1 |
| Jansén, CT | 1 |
| Takashima, A | 1 |
| Sunohara, A | 1 |
| Gold, RL | 1 |
| Anderson, RR | 1 |
| Natoli, VD | 1 |
| Kaidbey, K | 1 |
| Stolk, LM | 1 |
| Siddiqui, AH | 1 |
| Westerhof, W | 1 |
| Cormane, RH | 1 |
| Giles, A | 1 |
| Wamer, W | 1 |
| Kornhauser, A | 1 |
| Newmann, EA | 1 |
| Parker, RD | 1 |
| Bacchichetti, F | 1 |
| Antonello, C | 1 |
| Carlassare, F | 1 |
| Bordin, F | 1 |
| Douglas, WS | 1 |
| Railton, R | 1 |
| Newman, PN | 1 |
| Valtonen, EJ | 1 |
| Levine, GM | 1 |
| Harber, LC | 1 |
| Kahn, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Characterisation of the Time-course Response of UV-induced Erythema[NCT04290273] | 10 participants (Anticipated) | Interventional | 2023-09-30 | Not yet recruiting | |||
| Adaption of the Skin Sun Sensitivity Scale for People With All Pigment Varieties[NCT01975038] | 292 participants (Actual) | Observational | 2013-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for methoxsalen and Erythema
| Article | Year |
|---|---|
[Systemic photoallergy induced by methoxalen].
Topics: Adult; Erythema; Female; Humans; Male; Methoxsalen; Patch Tests; Photosensitivity Disorders; Psorias | 1992 |
Psoralen photochemotherapy--mechanisms, drugs, toxicity.
Topics: DNA; Erythema; Furocoumarins; Humans; Methoxsalen; Neoplasms, Radiation-Induced; Photosensitivity Di | 1986 |
5 trials available for methoxsalen and Erythema
| Article | Year |
|---|---|
Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
Topics: Action Spectrum; Adult; Aged; Analysis of Variance; Dermatitis, Phototoxic; Dose-Response Relationsh | 2016 |
The influence of infrared radiation on short-term ultraviolet-radiation-induced injuries.
Topics: Adult; Anthracenes; Erythema; Female; Humans; Infrared Rays; Male; Methoxsalen; Photosensitivity Dis | 1982 |
Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
Topics: Administration, Cutaneous; Adult; Aged; Dermatitis, Phototoxic; Erythema; Humans; Male; Methoxsalen; | 1998 |
Phototesting and dosimetry for photochemotherapy.
Topics: Body Weight; Clinical Trials as Topic; Erythema; Humans; Methoxsalen; Psoriasis; Skin Pigmentation; | 1977 |
Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Dose-Response Relationship, Drug; Erythema; Female; HL | 1988 |
62 other studies available for methoxsalen and Erythema
| Article | Year |
|---|---|
Concurrent evaluation of personal damaging and beneficial UV exposures over an extended period.
Topics: Erythema; Film Dosimetry; Humans; Methoxsalen; Phenols; Polymers; Seasons; Ultraviolet Rays; Vitamin | 2017 |
Time course for development of psoralen plus ultraviolet A erythema following oral administration of 5-methoxypsoralen.
Topics: 5-Methoxypsoralen; Adult; Aged; Erythema; Female; Humans; Male; Methoxsalen; Middle Aged; Photochemo | 2009 |
Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Erythema; Female; Gene Expression; Genoty | 2012 |
Miniature swine model of phototoxicity testing.
Topics: Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Evaluation, P | 2012 |
The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion.
Topics: Administration, Cutaneous; Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration | 2003 |
An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
Topics: Adult; Dose-Response Relationship, Drug; Erythema; Female; Humans; Male; Methoxsalen; Middle Aged; P | 2003 |
An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
Topics: Administration, Oral; Administration, Topical; Adult; Erythema; Female; Humans; Methoxsalen; Middle | 2003 |
Increased erythema threshold six weeks after a single exposure to sunlight plus oral methoxsalen.
Topics: Erythema; Furans; Humans; Methoxsalen; Sunburn; Sunlight | 1959 |
Normal skin reactions to ultraviolet light. I. An attempt to modify normal erythema and pigmentation with methoxsalen.
Topics: Erythema; Humans; Methoxsalen; Pigmentation; Skin Physiological Phenomena; Sunlight; Ultraviolet Ray | 1961 |
Erythema and tumor formation in methoxsalen-treated mice exposed to flourescent light.
Topics: Animals; Dermatitis, Phototoxic; Erythema; Humans; Light; Methoxsalen; Mice; Neoplasms; Photosensiti | 1960 |
Further studies demonstrating an increased erythemal threshold following oral methoxsalen.
Topics: Erythema; Humans; Methoxsalen; Skin Physiological Phenomena; Sunlight | 1960 |
The action spectrum of 8-methoxypsoralen for erythema in human skin. Preliminary studies with a monochromator.
Topics: Erythema; Humans; Methoxsalen; Skin; Sunburn | 1960 |
Can dietary furanocoumarin ingestion enhance the erythemal response during high-dose UVA1 therapy?
Topics: Adult; Aged; Apium; Diet; Erythema; Female; Food Handling; Furocoumarins; Hot Temperature; Humans; M | 2007 |
[Consensus document on bath-PUVA therapy. The Spanish Photobiology Group of the Spanish Academy of Dermatology and Venereology].
Topics: Administration, Cutaneous; Baths; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Dose-Res | 2007 |
Effect of UV-B erythema of psoralen, trimethylpsoralen, and 8 methoxypsoralen.
Topics: Adult; Dose-Response Relationship, Drug; Erythema; Female; Ficusin; Furocoumarins; Humans; Male; Met | 1980 |
Cutaneous phototoxicity due to psoralens.
Topics: Administration, Oral; Administration, Topical; Animals; DNA; Dose-Response Relationship, Drug; Eryth | 1984 |
Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time.
Topics: Administration, Topical; Adult; Erythema; Female; Humans; Male; Methoxsalen; Photochemotherapy; Phot | 1984 |
PUVA-induced erythema and changes in mechanoelectrical properties of skin. Inhibition by tocopherols.
Topics: Animals; Antioxidants; Erythema; Galvanic Skin Response; Humans; Methoxsalen; Photochemotherapy; PUV | 1984 |
In vivo effects of PUVA on lymphocytes function.
Topics: Adult; B-Lymphocytes; Dose-Response Relationship, Drug; Erythema; Humans; Leukocyte Count; Lymphocyt | 1981 |
Cumulative effects from repeated exposures to ultraviolet radiation.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Erythema | 1981 |
[Alpha-tocopherol inhibition of erythema in skin photosensitized by 8-methoxypsoralen].
Topics: Animals; Erythema; Male; Methoxsalen; Photosensitivity Disorders; Rabbits; Skin; Ultraviolet Rays; V | 1980 |
Synthesis and photobiological properties of 4-hydroxymethyl-4'-methylpsoralen derivatives.
Topics: Animals; DNA; Dose-Response Relationship, Radiation; Erythema; Furocoumarins; Guinea Pigs; Methoxsal | 1993 |
A polychromatic action spectrum for photosensitivity to orally administered 8-methoxypsoralen in humans.
Topics: Administration, Oral; Adult; Dermatitis, Phototoxic; Dose-Response Relationship, Radiation; Erythema | 1994 |
Response of psoriasis to twice weekly PUVA.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; H | 1993 |
PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Topics: Adult; Aged; Dose-Response Relationship, Radiation; Erythema; Female; Humans; Male; Methoxsalen; Mid | 1993 |
Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by polypodium leucotomos.
Topics: Animals; Antioxidants; Erythema; Guinea Pigs; Humans; In Vitro Techniques; Lipid Peroxidation; Metho | 1996 |
Modulation of 8-methoxypsoralen-photoinduced cutaneous inflammatory reactions by various chemotherapeutic agents in vivo.
Topics: Acetophenones; Animals; Capillary Permeability; Erythema; Ibuprofen; Indoles; Indomethacin; Masoproc | 1996 |
Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Topics: Baths; Dose-Response Relationship, Drug; Erythema; Humans; Methoxsalen; Photosensitizing Agents; PUV | 1996 |
Comparative studies on the tolerance to photoinduced cutaneous inflammatory reactions by psoralen and rose bengal.
Topics: Animals; Capillary Permeability; Dermatitis, Phototoxic; Desensitization, Immunologic; Erythema; Fic | 1997 |
Antiproliferative activity and phototoxicity of some methyl derivatives of 5-methoxypsoralen and 5-methoxyangelicin.
Topics: 5-Methoxypsoralen; Animals; Antineoplastic Agents; Cell Division; Dermatitis, Phototoxic; Dose-Respo | 1998 |
Psoralen-ultraviolet A-induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid.
Topics: Adolescent; Adult; Blister; Erythema; Female; Humans; Male; Methoxsalen; Middle Aged; Predictive Val | 2000 |
Correlation between bathing time and photosensitivity in 8-methoxypsoralen (8-MOP) bath PUVA.
Topics: Adult; Baths; Erythema; Humans; Methoxsalen; PUVA Therapy; Statistics, Nonparametric; Time Factors | 2000 |
Reduction in 8-methoxypsoralen immersion time alters the erythemal response to bath PUVA.
Topics: Adult; Baths; Erythema; Female; Forearm; Humans; Linear Models; Male; Methoxsalen; PUVA Therapy; Sta | 2000 |
The effect of methoxsalen dose on ultraviolet-A-induced erythema.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Erythema; Huma | 2001 |
Can the immersion time of PUVA bath therapy be shortened?
Topics: Baths; Dose-Response Relationship, Drug; Erythema; Female; Follow-Up Studies; Humans; Immersion; Mal | 2002 |
Photochemotherapy for psoriasis--PUVA breaking through "the heartbreak".
Topics: Adult; Drug Eruptions; Erythema; Humans; Methoxsalen; Middle Aged; Photochemotherapy; Psoriasis; Ult | 1978 |
Inflammatory reactions induced by ultraviolet irradiation.
Topics: Arachidonic Acids; Cell Differentiation; Cyclic AMP; Erythema; Humans; Indomethacin; Inflammation; M | 1978 |
Photochemotherapy of psoriasis (PUVA).
Topics: Administration, Oral; Adolescent; Erythema; Female; Humans; Methoxsalen; Nausea; Photochemotherapy; | 1979 |
Ultraviolet radiation-induced inflammation and leukocytes.
Topics: Animals; Cell Count; Cyclophosphamide; Erythema; Guinea Pigs; Inflammation; Leukocytes; Leukopenia; | 1979 |
Histological changes produced in skin by equally erythemogenic doses of UV-A, UV-B, UV-C and UV-A with psoralens.
Topics: Adult; Erythema; Female; Humans; Male; Methoxsalen; Photochemotherapy; Radiation Dosage; Skin; Ultra | 1979 |
A new apparatus for the delivery of high intensity UVA and UVA+UVB irradiation, and some dermatological applications.
Topics: Acrodermatitis; Adult; Aged; Erythema; Erythropoiesis; Female; Humans; Male; Methoxsalen; Photochemo | 1978 |
Photochemotherapy in psoriasis: the first six months in Australia.
Topics: Australia; Darier Disease; Dermatitis; Edema; Erythema; Humans; Methoxsalen; Photochemotherapy; Prur | 1979 |
Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Child, Preschool; Erythema; Female; Humans; Ma | 1977 |
Phototoxicity and photocarcinogenesis: comparative effects of anthracene and 8-methoxypsoralen in the skin of mice.
Topics: Animals; Anthracenes; Erythema; Methoxsalen; Mice; Neoplasms; Neoplasms, Experimental; Neoplasms, Ra | 1976 |
Further studies of photoaugmentation in humans: phototoxic reactions.
Topics: Adult; Coal Tar; Erythema; Humans; Male; Methoxsalen; Photosensitivity Disorders; Sunburn; Ultraviol | 1975 |
Simplification of local therapy of psoriasis with 8-methoxypsoralen. Methods and initial results.
Topics: Erythema; Evaluation Studies as Topic; Female; Humans; Male; Methoxsalen; Oils; Ointment Bases; Pigm | 1976 |
Photoinduced cutaneous inflammatory response by psoralens.
Topics: Administration, Topical; Animals; Darkness; Dose-Response Relationship, Drug; Erythema; Inflammation | 1992 |
An action spectrum for the elicitation of erythema in skin persistently sensitized by photobound 8-methoxypsoralen.
Topics: Erythema; Humans; Methoxsalen | 1991 |
The relationship between plasma psoralen concentration and psoralen-UVA erythema.
Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiat | 1991 |
An action spectrum for the elicitation of erythema in skin persistently sensitized by photobound 8-methoxypsoralen.
Topics: Differential Threshold; Dose-Response Relationship, Radiation; Erythema; Humans; Light; Methoxsalen; | 1990 |
A possible role of prostaglandins in PUVA-induced inflammation: implication by organ cultured skin.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Dermatitis; Erythema; Guinea Pigs; Methoxsalen; Organ | 1989 |
Comparison of the relative therapeutic efficacy of 7-methyl pyridopsoralen and 8-methoxypsoralen in photochemotherapy in psoriasis treatment.
Topics: Adult; Aged; Erythema; Female; Furocoumarins; Humans; Male; Methoxsalen; Middle Aged; Photochemother | 1988 |
An action spectrum for photoinduction of prolonged cutaneous photosensitivity by topical 8-MOP.
Topics: Cross-Linking Reagents; DNA Damage; Dose-Response Relationship, Drug; Erythema; Humans; Methoxsalen; | 1988 |
Comparison of methods for assessing photoprotection against ultraviolet A in vivo.
Topics: Adolescent; Adult; Anthracenes; Benzoates; Benzophenones; Chalcones; Erythema; Female; Humans; Male; | 1987 |
Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen.
Topics: 5-Methoxypsoralen; Administration, Oral; Adult; Aged; Biological Availability; Capsules; Erythema; F | 1985 |
In vivo protective effect of beta-carotene against psoralen phototoxicity.
Topics: Animals; beta Carotene; Carotenoids; Erythema; Female; Methoxsalen; Rats; Rats, Inbred Strains; Skin | 1985 |
A device for irradiating guinea-pig skin with ultraviolet light.
Topics: Animals; Erythema; Guinea Pigs; Methoxsalen; Ultraviolet Rays | 1985 |
Photobiological properties of some water-soluble 5-MOP and 8-MOP derivatives.
Topics: 5-Methoxypsoralen; Animals; Carcinoma, Ehrlich Tumor; Cell Division; DNA; Erythema; Guinea Pigs; Met | 1985 |
Sunscreens and PUVA.
Topics: Erythema; Humans; Methoxsalen; PUVA Therapy; Skin Neoplasms; Spectrophotometry, Ultraviolet; Sunscre | 1985 |
Studies of the mechanism of ultra-violet erythema formation. 3. A method for biological testing of ultra-violet radiation sources and substances affecting the degree of erythema.
Topics: Aminopyrine; Animals; Erythema; Methoxsalen; Mice; Phenylbutazone; Skin; Ultraviolet Rays | 1966 |
The effect of humidity on the phototoxic response to 8-methoxypsoralen in guinea pigs.
Topics: Animals; Erythema; Guinea Pigs; Humidity; Methoxsalen; Photosensitivity Disorders; Skin Absorption | 1969 |
Intensified contact sensitization to benzyl salicylate. Phototoxic effects of topical psoralen therapy.
Topics: Adolescent; Adult; Child; Dermatitis, Contact; Erythema; Female; Humans; Hypersensitivity, Delayed; | 1971 |